Skip to content

Platform
Focus
News
Team
Careers

News

Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies

Genetic Medicines for Every Patient.

Focus
Platform
Team
News
Careers

Contact Us LinkedIn Twitter

© 2025

Kelonia Therapeutics, Inc. All Rights Reserved. Privacy Policy. Terms of Use.

Top